Physician profile
David C Dome
NPI 1801826862
$4,186.48
in general payments reported to CMS, 2019-2025
9 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,311 · 2023: $812 · 2024: $1,915 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,535 · Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,535.09 |
| Food and Beverage | $1,340.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $1,559.16 | 2021-2024 | |
| Arthrex, INC. | $1,465.07 | 2023-2024 | |
| Smith+Nephew, INC. | $545.55 | 2023-2024 | Firstpass, Novostitch, Acufex Meniscal Root Repair |
| Anika Therapeutics, INC. | $159.58 | 2023 | Tactoset |
| Zimmer Biomet Holdings, INC. | $147.69 | 2023 | |
| Depuy Synthes Sales INC. | $111.19 | 2021 | |
| Stryker Corporation | $101.50 | 2025 | Blueprint Patient Specific Instrumentation |
| Blue Surgical LLC | $79.43 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $17.31 | 2024 | Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dome listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.